Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 Deals-lir 5 Dx Deals: Veracyte Acquires Convergent Genomics for up to $180 Million

Dx Deals: Veracyte Acquires Convergent Genomics for up to $180 Million

by | Oct 16, 2026 | Deals-lir, Essential, Lab Industry Advisor

The deal gives the oncology-focused Veracyte a boost in bladder cancer detection

Subscribe to view Essential

Start a Free Trial for immediate access to this article